arrow
J

Javier Martín-Broto

instituto de investigacion sanitaria fundacion jimenez diaz
H指数:60
被引数:1.3万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Long-term efficacy, clinical outcomes, and safety of vimseltinib in patients with tenosynovial giant cell tumor: results from the MOTION phase 3 trial

维美替尼在腱鞘巨细胞瘤患者中的长期疗效、临床结局及安全性:MOTION III期试验结果

2026-10-190
OAAI
Evolution of Treatment Strategies and Surgical Outcomes in Desmoid Tumors: A Retrospective Cohort Study

结节性筋膜炎的治疗策略演变与手术结果:一项回顾性队列研究

EJSO
IF2.9
2026-09-210
PRE
Biomarkers of prognosis and pazopanib response in soft tissue sarcoma: An exploratory analysis

软组织肉瘤的预后和帕唑帕尼治疗反应的生物标志物:一项探索性分析

2026-07-310
PRE
NAB2::STAT6 Fusion Proteins Drive Nuclear Condensate Formation and Transcriptional Reprogramming in Solitary Fibrous Tumors

NAB2::STAT6融合蛋白驱动孤立性纤维瘤中核凝聚体的形成和转录重编程

2026-05-220
OAAI
Initial report from the SAR-TRACK (SELNET) registry: a multicentric international retrospective analysis on the quality of the management of limb and trunk wall soft-tissue sarcomas (2012–2022) in Ibero-American countries

SAR-TRACK (SELNET)注册研究初步报告:一项关于伊比利亚美洲国家肢体和躯干壁软组织肉瘤(2012–2022)管理质量的跨国多中心回顾性分析

2026-02-170
OAAI
Global to local burdens, inequalities, and achievable frontiers of child and adolescent malignant neoplasm of bone and articular cartilage across 953 countries and sublocations, 1980–2040, with deep learning-based forecasts

1980至2040,基于深度学习的预测,953个国家和地区的儿童和青少年骨和关节软骨恶性肿瘤的全球到地方负担,不平等和可实现的边界

2026-02-020
OAAI
Gemcitabine plus selinexor in selective advanced sarcomas: a phase I of the Spanish group for research on sarcoma study

选择性晚期肉瘤中的吉西他滨加selinexor: 西班牙肉瘤研究小组的第一阶段

2026-01-200
OAAI
VEGF Signaling Pathway Germline Polymorphisms as Prognostic Pharmacogenetic Biomarkers in Localized High-Grade Osteosarcoma Patients from the GEIS-33 Protocol

VEGF信号通路生殖系多态性作为来自GEIS-33方案局部高级别骨肉瘤患者的预后药物基因组学生物标志物

2025-12-050
OAAI
Spatial immunoprofiling of retroperitoneal leiomyosarcomas reveals intratumoral heterogeneity in immune cell infiltration, checkpoint molecule expression, and tertiary lymphoid structures

腹膜后平滑肌肉瘤的空间免疫组化分析揭示了肿瘤内部在免疫细胞浸润、检查点分子表达和三级淋巴结构方面的异质性。

2025-10-130
OAAI
Diagnosis and Therapy of Soft Tissue Sarcomas: Spanish Group for Research in Sarcomas (GEIS) Guidelines

软组织肉瘤的诊断与治疗:西班牙肉瘤研究组(GEIS)指南

2025-09-290
OAAI
Sinonasal Sarcomas Management: An International Consensus Statement

鼻腔鼻窦肉瘤的管理:一项国际共识声明

2025-09-010
OAAI
Genomics-led approach to drug testing in models of undifferentiated pleomorphic sarcoma

基因组学导向的方法在未分化多形性肉瘤模型中的药物测试

2025-05-260
OAAI
SaLudo: a randomized phase IIb/III study of lurbinectedin plus doxorubicin as first-line treatment in leiomyosarcoma

SaLudo: lurbinectedin加阿霉素作为平滑肌肉瘤一线治疗的随机IIb/III期研究

2025-02-110
OAAI
Nivolumab and sunitinib in patients with advanced bone sarcomas: A multicenter, single-arm, phase 2 trial
CANCER
IF5.1
2024-11-141
PRE
Exploratory analysis of immunomodulatory factors identifies L1CAM as a prognostic marker in alveolar soft-part sarcoma
2024-11-040
OAAI